Marion R. Foote

Director, CASCADE FINANCIAL CORP.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 30, 2025Returned to company 165,156 shares of Proteostasis Therapeutics (United States)⁴
Jun 25, 2025Granted 6,000 shares of Proteostasis Therapeutics (United States)⁵
Jun 23, 2025Shares withheld for tax 4,706 shares at $0.26 of Proteostasis Therapeutics (United States)⁵
Jun 23, 2025Exercised options 12,500 shares at $0.61 of Proteostasis Therapeutics (United States)⁵
Jun 17, 2025Exercised options 8,158 shares at $0.14 of Proteostasis Therapeutics (United States)⁶
Oct 11, 2023Exercised options 4,443 shares at $0.14 of Proteostasis Therapeutics (United States)⁷
Dec 16, 2022Granted 21,645 shares at $11.55 of Proteostasis Therapeutics (United States)⁸
Dec 16, 2022Granted 860 shares of Proteostasis Therapeutics (United States)⁸
Dec 16, 2022Granted 3,440 shares of Proteostasis Therapeutics (United States)⁸
Dec 16, 2022Granted 656 shares of Proteostasis Therapeutics (United States)⁸
Dec 16, 2022Granted 112,160 shares of Proteostasis Therapeutics (United States)⁸
Oct 19, 2022Returned to company 364,341 shares at $93.50 of AVALARA, INC.³
Oct 17, 2022Gift 32,100 shares of AVALARA, INC.³
Jun 8, 2022Granted 2,254 shares of AVALARA, INC.⁹
Dec 17, 2021Gift 75,000 shares of AVALARA, INC.¹⁰

The numbers on this page point here. Each one links to the record it came from.